Built from weaker models, sales multiples or analyst targets, so treat it as a rough guide.
Not used by alerts or posts.
Valued as a cyclical company: Discounted cash flow.
ACCE opinionTron Inc. Common Stock (TRON)
Fair value
Not available
ACCE price target
$0.61
Rating
Not rated
Horizon
12 months
ACCE price target published on 15 Oct 2026, 00:00 CEST.
Price used: $1.44 at the close on 23 Oct 2026, 22:00 CEST.
Models: Discounted cash flow.
Fair value: the average of the applicable valuation models (discounted cash flow, multiples, residual income, dividend discount, shareholder yield), each run on the latest financial statements and the market price shown. Opinion columns (fair value, target, rating) are shown apart from the data. Full methodology: acceinvestments.com/data/how-we-value-stocks
Conflicts of interest: The author holds no personal position in this security. General statement
Produced by ACCE Investments (acceinvestments.com)
Data
ACCE score
33
out of 100
1-year return
-45.9%
Dividend yield
0.00%
Tron Inc. Common Stock in four questions
Plain answers, details below
Free accounts get 5 full stock pages a month, including the four answers.
Overview
ACCE thesis
Tron Inc. operates the Tron Edge and related dental and sleep-related product lines, and it is still a small, loss-making business with a 24.7% gross margin and a -32.5% operating margin. Revenue growth of 16.8% is the one clear positive in the numbers provided, but it has not yet translated into operating profit, and a PE of 0.0 means there are no earnings to anchor a valuation. The next test is whether gross margin expands as volume scales, since that is the only route to the operating break-even the current cost base requires. At a 3.8% ROE and a 33/100 score, the name does not yet meet our bar, though a deeper look would be justified only if management can show a credible path from 16.8% top-line growth to positive operating leverage.